beta.(1-3) glucan is used clinically as an immune stimulator. This patent teaches that beta glucan can be used to stimulate production of platelets by acting at the level of the hematopoietic stem cell. Beta glucan's mechanism of doing this appears to be currently unknown.
Given the wide availablity and safety profile of beta glucan, this patent is useful for clinical development if proper formulations can be made.
View this patent on the USPTO website.
You must be signed-in to add your comments.
Sign-in now or Join the StemCellPatents.com Community for free.